
    
      After a screening visit and a one-week washout (if applicable), three sequential ascending
      doses of the study drug will be applied twice-daily (BID) for 14 days in three groups of
      subjects. Each group of subjects will be randomized to receive the planned doses of B244 or
      placebo BID
    
  